Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China; Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, China.
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China; Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, China; Gansu University of Traditional Chinese Medicine, Lanzhou, China.
Complement Ther Med. 2020 Aug;52:102433. doi: 10.1016/j.ctim.2020.102433. Epub 2020 Jun 10.
To investigate the reporting quality and risk of bias of randomized controlled trials (RCTs) of acupuncture for migraine, to facilitate and improve the quality of RCTs of acupuncture for migraine.
The Cochrane Library, PubMed and EMBASE were searched from inception to June 11, 2019 using a comprehensive search strategy. The reporting quality and risk of bias of included RCTs were independently evaluated by two investigators using STRICTA and RoB 2.0. Any disagreement was resolved by a third investigator.
A total of 28 eligible RCTs were published in 24 academic journals from 1994 to 2018. Based on STRICTA, four sub-items including "details of other interventions'' (1/28, 4 %), "setting and context of treatment" (9/28, 32 %), "the extent to which treatment was varied" (11/28, 39 %), and "number of needle insertions per subject per session" (13/28, 46 %), showed low reporting quality. A total of 32 different outcomes were reported in 28 RCTs, and based on RoB 2.0, nine (9/28, 32 %) RCTs were judged to be high RoB, three of which were owing to deviations from intended interventions; 11(11/28, 39 %) RCTs elicited some concerns; and eight (8/28, 29 %) RCTs were low RoB for their outcomes.
The reporting quality and risk of bias of RCTs of acupuncture for migraine remain suboptimal. Therefore, all stakeholders should make a contribution to improve the quality of RCTs of acupuncture for migraine using STRICTA and RoB 2.0, while not limiting this approach solely to studies on migraine, using STRICTA and RoB 2.0 tools.
调查针刺治疗偏头痛的随机对照试验(RCT)的报告质量和偏倚风险,以促进和提高针刺治疗偏头痛的 RCT 质量。
系统检索 Cochrane 图书馆、PubMed 和 EMBASE 从建库至 2019 年 6 月 11 日的相关文献,采用全面的检索策略。由 2 名评价员独立使用 STRICTA 和 RoB 2.0 评价纳入 RCT 的报告质量和偏倚风险,意见不一致时由第 3 名评价员裁定。
共纳入 24 种期刊上 1994 年至 2018 年发表的 28 项 RCT。基于 STRICTA,4 个亚项(包括“其他干预措施的详细信息”[1/28,4%]、“治疗的设置和背景”[9/28,32%]、“治疗的变化程度”[11/28,39%]和“每个受试者每个疗程的针刺次数”[13/28,46%])的报告质量较低。28 项 RCT 共报告了 32 个不同的结局,基于 RoB 2.0,9 项(9/28,32%)RCT 被判断为高偏倚风险,其中 3 项归因于对干预措施的偏离;11 项(11/28,39%)RCT 存在一些关注问题;8 项(8/28,29%)RCT 为低偏倚风险。
针刺治疗偏头痛的 RCT 报告质量和偏倚风险仍不理想。因此,所有利益相关者都应使用 STRICTA 和 RoB 2.0 来提高针刺治疗偏头痛的 RCT 质量,而不仅仅将这种方法局限于偏头痛研究,同时使用 STRICTA 和 RoB 2.0 工具。